Study in JAMA Pediatrics links specific metabolites in newborn screenings to a 14-fold increased SIDS risk.

A study in JAMA Pediatrics indicates that specific metabolites identified in newborn screenings may help predict Sudden Infant Death Syndrome (SIDS) risk. Researchers analyzed data from California infants born between 2005 and 2011, finding that certain metabolite levels correlated with a 14-fold increase in SIDS risk. While the findings suggest metabolic issues may contribute to SIDS, further research is needed to confirm these links and explore potential interventions.